LP-118

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory NHL, RT, MM, T-PLL, Acute Leukemia (AML, ALL), MDS, MDS/MPN, and MF

Arms / Cohorts

Experimental:Multiple Myeloma Patients: Dose Escalation

Accepting patients

Experimental:MDS Patients: Dose Escalation

Accepting patients

Experimental:MDS/MPN Patients: Dose Escalation

Accepting patients

Experimental:Multiple Myeloma Patients: Dose Expansion

Not yet accepting

Experimental:MDS Patients: Dose Expansion

Not yet accepting

Experimental:MDS/MPN Patients: Dose Expansion

Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.